Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.12
+0.04 (0.79%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Lifecore Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2025 FY 2024 FY 2023 FY 2022 2021 - 2017
Period Ending
Apr '26 Dec '25 May '25 May '24 May '23 May '22 2021 - 2017
Market Capitalization
192306249172241291
Upgrade
Market Cap Growth
-10.96%23.18%44.93%-28.69%-17.27%-17.12%
Upgrade
Enterprise Value
318472419305395424
Upgrade
Last Close Price
5.128.186.725.627.949.87
Upgrade
PE Ratio
---14.29--
Upgrade
Forward PE
---25.55--
Upgrade
PS Ratio
1.482.371.931.342.332.62
Upgrade
PB Ratio
5.639.005.253.196.863.31
Upgrade
P/TBV Ratio
-----4.17
Upgrade
P/FCF Ratio
30.8049.20----
Upgrade
P/OCF Ratio
15.2724.39-667.99--
Upgrade
PEG Ratio
-0.920.920.920.920.92
Upgrade
EV/Sales Ratio
2.463.653.252.373.823.81
Upgrade
EV/EBITDA Ratio
38.6057.32-123.49-29.82
Upgrade
EV/FCF Ratio
51.0775.84----
Upgrade
Debt / Equity Ratio
4.224.222.762.393.211.71
Upgrade
Debt / EBITDA Ratio
16.8316.83-43.34-9.63
Upgrade
Debt / FCF Ratio
23.0723.07----
Upgrade
Net Debt / Equity Ratio
3.713.712.582.232.671.70
Upgrade
Net Debt / EBITDA Ratio
15.3215.32-30.8048.73-13.2810.49
Upgrade
Net Debt / FCF Ratio
20.2720.27-9.00-6.62-2.40-2.84
Upgrade
Asset Turnover
--0.520.510.390.29
Upgrade
Inventory Turnover
--2.452.141.961.46
Upgrade
Quick Ratio
2.182.181.461.021.230.22
Upgrade
Current Ratio
3.493.492.842.092.390.66
Upgrade
Return on Equity (ROE)
---76.41%20.97%-104.52%-10.65%
Upgrade
Return on Assets (ROA)
---3.04%-1.35%-4.67%-0.55%
Upgrade
Return on Invested Capital (ROIC)
-0.76%-0.76%-6.98%-3.56%-10.79%-1.05%
Upgrade
Return on Capital Employed (ROCE)
-0.60%-0.60%-5.70%-2.60%-9.20%-3.50%
Upgrade
Earnings Yield
-17.98%-10.05%-15.56%7.00%-41.36%-40.11%
Upgrade
FCF Yield
3.25%2.03%-5.47%-10.56%-16.17%-18.05%
Upgrade
Buyback Yield / Dilution
-1.63%-7.33%5.02%-22.36%-1.67%-0.59%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.